ScholarWorks@Hanyang University ERICA Campus

Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Synthesis of aminoquinazoline derivatives and their antiproliferative activities against melanoma cell line

Full metadata record
DC Field Value Language
dc.contributor.authorLee, Junsang-
dc.contributor.authorNam, Bong Soo-
dc.contributor.authorKim, Hwan-
dc.contributor.authorOh, Chang-Hyun-
dc.contributor.authorLee, So Ha-
dc.contributor.authorCho, Seung Joo-
dc.contributor.authorSim, Tae Bo-
dc.contributor.authorHah, Jung-Mi-
dc.contributor.authorKim, Dong Jin-
dc.contributor.authorTae, Jinsung-
dc.contributor.authorYoo, Kyung Ho-
dc.date.accessioned2021-06-23T12:39:57Z-
dc.date.available2021-06-23T12:39:57Z-
dc.date.issued2010-10-
dc.identifier.issn0960-894X-
dc.identifier.issn1464-3405-
dc.identifier.urihttps://scholarworks.bwise.kr/erica/handle/2021.sw.erica/39464-
dc.description.abstractThe synthesis of a novel series of aminoquinazoline derivatives 1a-r and their antiproliferative activities against A375 human melanoma cell line were described. Among them, six compounds showed superior antiproliferative activities to Sorafenib as a reference compound. In particular, the representative compound 1q bearing chromen-4-one moiety exhibited excellent antiproliferative activity (IC50 = 0.006 mu M) and good selectivity over HS27 fibroblast cell line. (C) 2010 Elsevier Ltd. All rights reserved.-
dc.format.extent4-
dc.language영어-
dc.language.isoENG-
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD-
dc.titleSynthesis of aminoquinazoline derivatives and their antiproliferative activities against melanoma cell line-
dc.typeArticle-
dc.publisher.location영국-
dc.identifier.doi10.1016/j.bmcl.2010.08.010-
dc.identifier.scopusid2-s2.0-77957592790-
dc.identifier.wosid000281735600026-
dc.identifier.bibliographicCitationBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.20, no.19, pp 5722 - 5725-
dc.citation.titleBIOORGANIC & MEDICINAL CHEMISTRY LETTERS-
dc.citation.volume20-
dc.citation.number19-
dc.citation.startPage5722-
dc.citation.endPage5725-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClasssci-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalResearchAreaChemistry-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalWebOfScienceCategoryChemistry, Organic-
dc.subject.keywordPlusRANDOMIZED PHASE-III-
dc.subject.keywordPlusMETASTATIC MELANOMA-
dc.subject.keywordPlusMALIGNANT-MELANOMA-
dc.subject.keywordPlusDACARBAZINE-
dc.subject.keywordPlusCHEMOTHERAPY-
dc.subject.keywordPlusCISPLATIN-
dc.subject.keywordPlusINTERLEUKIN-2-
dc.subject.keywordPlusFOTEMUSTINE-
dc.subject.keywordPlusEXPERIENCE-
dc.subject.keywordPlusTHERAPY-
dc.subject.keywordAuthorAminoquinazolines-
dc.subject.keywordAuthorSynthesis-
dc.subject.keywordAuthorAntiproliferative activity-
dc.subject.keywordAuthorA375 human melanoma cell line-
dc.subject.keywordAuthorSelectivity-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0960894X10011200?via%3Dihub-
Files in This Item
Go to Link
Appears in
Collections
COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles
Show simple item record

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Hah, Jung Mi photo

Hah, Jung Mi
COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)
Read more

Altmetrics

Total Views & Downloads

CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr

COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어